Search Results - "Tornic, J."

Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany by Schindler, O, Ho, H, Leidl, Q, Angermund, A, Elishar, R, Frech-Dörfler, M, Hirsch, A, Kalke, Y-B, Kirschner-Herrmanns, R, Tornic, J, Queissert, F, Rahnama'i, S, Rehme, C, Reitz, A, Schmitz, F, Schultz-Lampel, D, Gedamke, M

“…Existing therapies for neurogenic detrusor overactivity (NDO), i.e. oral anticholinergics and botulinum toxin injections, can be associated with serious…”
Get more information

Efficacy and safety of sacral neuromodulation for neurogenic lower urinary tract dysfunction: a randomised, sham-controlled, double-blind, multicentre clinical trial by Liechti, M.D., Van Der Lely, S., Knüpfer, S.C., Abt, D., Kiss, B., Leitner, L., Mordasini, L., Tornic, J., Wöllner, J., Mehnert, U., Bachmann, L.M., Burkhard, F.C., Engeler, D.S., Pannek, J., Kessler, T.M.

Get full text

Acute lung injury: apoptosis in effector and target cells of the upper and lower airway compartment by Z'graggen, B. Roth, Tornic, J, Müller-Edenborn, B, Reyes, L, Booy, C, Beck-Schimmer, B

“…Apoptotic cell death has been considered an underlying mechanism in acute lung injury. To evaluate the evidence of this process, apoptosis rate was determined…”
Get full text

Detrusor acontractility after acute spinal cord injury: Myth or reality by Bywater, M, Tornic, J, Mehnert, U, Kessler, T

Get full text

The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis by Tornic, Jure, Panicker, Jalesh N.

“…Purpose of Review Multiple sclerosis (MS) is the most frequent neuroinflammatory disease of the central nervous system and is commonly associated with lower…”
Get full text

464 FlowSecure™ artificial urinary sphincter: Can low-pressure and stress-relief-mechanism be confirmed by urethral profilometry? by Haab, A.C, Tornic, J, John, H

Get full text

109 - Assessment of sensory qualities of neobladders during storage phase and correlation to video-urodynamic parameters in patients after robotic-assisted radical cystectomy: A cohort Study by Boehler, K, Kraft, P, Frölicher, G, Obrecht, F, Schregel, C, Förster, B, John, H, Tornic, J

Get full text

Voiding Function and Dysfunction, Bladder Physiology and Pharmacology, and Female Urology by Wein, Alan J.

Get full text

657 More than 15 years experience with intradetrusor onabotulinumtoxinA injections for treating refractory neurogenic detrusor overactivity: Lessons to be learned by Tornic, J, Leitner, L, Guggenbühl, S, Walter, M, Knüpfer, S, Schneider, M.P, Mehnert, U, Kessler, T.M

Get full text

1113 Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: Do we need urodynamic investigation for outcome assessment? by Tornic, J, Leitner, L, Koschorke, M, Walter, M, Knüpfer, S, Schneider, M.P, Mehnert, U, Kessler, T.M

Get full text

167 - Detrusor acontractility after acute spinal cord injury: Myth or reality by Bywater, M., Tornic, J., Mehnert, U., Kessler, T.

Get full text

Intravesikale Oxybutynin-Behandlung der neurogenen Detrusorüberaktivität by Schindler, O, Ho, H, Leidl, Q, Angermund, A, Elishar, R, Frech-Dörfler, M, Hirsch, A, Kalke, Y.-B, Kirschner-Herrmanns, R, Tornic, J, Queissert, F, Rahnama’i, S, Rehme, C, Reitz, A, Schmitz, F, Schultz-Lampel, D, Gedamke, M

“…Bestehende Therapien für die neurogene Detrusorüberaktivität (NDO), d. h. orale Anticholinergika und Botulinumtoxin-Injektionen, können schwerwiegende…”
Get full text